IFNA1 and COVID-19: Furthermore, COVID-19 could have revealed a pre-existing autoimmune condition/predisposition: the woman might have had previously DM-like skin rash, and SARS-CoV-2 infection could have unveiled overt disease by eliciting a strong IFN signature.